UBE2L6 and acute myeloid leukemia: We first examined UBE2L6 mRNA expression in 98 primary AML patient samples (M0–M4), six samples of normal CD34+ (HSC) cells, and 24 donated mature granulocyte samples using a TaqMan low‐density array.